PTEN and cancer: These studies further solidify the mechanism by which PRL2 promotes tumorigenesis via the down-regulation of PTEN and establish PTEN restoration by PRL2 inhibition as a therapeutic approach for cancer treatment in both PTEN deficient and wildtype (WT) backgrounds.